Pvalue | ||||
---|---|---|---|---|
Treatment A (n= 14) | Treatment B (n= 11) | Time | Treatment × Compliance × Time | |
DAS28 | -1.8 (-2.6 to -1.0) | -1.9 (-2.8 to -1.0) | <0.001 | 0.59 |
ESRa | -0.62 (-1.07 to -0.18) | -0.49 (-0.99 to 0.02) | 0.003 | 0.78 |
HAQ | -0.27 (-0.50 to -0.04) | -0.43 (-0.69 to -0.17) | <0.001 | 0.82 |
Leptina | 0.25 (0.02 to 0.48) | 0.32 (0.05 to 0.59) | <0.001 | 0.07 |
Adiponectin | 1.66 (0.16 to 3.17) | 2.33 (-0.27 to 4.93) | <0.001 | 0.058 |
Apolipoprotein A1 | 0.09 (-0.08 to 0.26) | 0.19 (-0.01 to 0.39) | 0.004 | 0.45 |
Apolipoprotein B | -0.06 (-0.16 to 0.03) | 0.07 (-0.04 to 0.18) | 0.59 | 0.33 |
ApoB/ApoA1 | 0.09 (-0.19 to 0.00) | -0.01 (-0.12 to 0.10) | 0.023 | 0.56 |
P1NPa | -0.02 (-0.030 to 0.25) | -0.29 (-0.61 to 0.03) | 0.004 | 0.82 |
CTX1a | -0.25 (-0.64 to 0.14) | -0.47 (-0.62 to 0.28) | <0.001 | 0.11 |
1CTPa | -0.05 (-0.27 to 0.16) | -0.21 (-0.46 to 0.04) | <0.001 | 0.76 |
P1NP/CTX-1a | 0.23 (-0.04 to 0.49) | -0.10 (-0.41 to 0.21) | 0.023 | 0.08 |
P1NP/1CTPa | 0.03 (-0.28 to 0.34) | -0.08 (-0.44 to 0.28) | 0.45 | 0.56 |
IGF-1a | 0.06 (-0.07 to 0.18) | -0.02 (-0.17 to 0.13) | 0.050 | 0.08 |
IGF-1 SD score | 0.32 (-0.14 to 0.78) | 0.02 (-0.52 to 0.56) | 0.003 | 0.12 |